BridgeBio Pharma Inc. (NASDAQ: BBIO) reported Q1 EPS of ($0.88), $0.03 better than the analyst estimate of ($0.91). Revenue for the quarter came in at $116.63 million versus the consensus estimate of $54.46 million.

For earnings history and earnings-related data on BridgeBio Pharma Inc. (BBIO) click here.